PDCD10 and neoplasm: High PDCD10 levels correlate with poor prognosis, and targeting PP2Ac with inhibitors like LB100 effectively suppresses tumor growth and metastasis, supporting PDCD10 as a potential target for therapy (Sun et al., 2021[140]).